Oncolys BioPharma Inc. (TYO:4588)

Oncolys BioPharma Revenue

Oncolys BioPharma had revenue of 500.00M JPY in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 28.55M, down -9.04% year-over-year. In the year 2024, Oncolys BioPharma had annual revenue of 31.38M, down -50.21%. That makes Oncolys BioPharma the 45,590th largest company in the world by revenue and 3,871st in Japan.

• Revenue (ttm): 28.55M
• Revenue Growth: -9.04%
• P/S Ratio: 6,507.40
• Revenue / Employee: 679.67K
• Employees: 45
• Market Cap: 185.76B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 35.00M 55.5%
• United States of America 28.04M 44.5%

Fiscal year ended Dec 31, 2023 See the full Oncolys BioPharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.38M	-31.65M	-50.21%
Dec 31, 2023	63.04M	-913.14M	-93.54%
Dec 31, 2022	976.18M	333.69M	51.94%
Dec 31, 2021	642.49M	328.32M	104.50%
Dec 31, 2020	314.18M	-989.67M	-75.90%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error